A recent meta-analysis has shown an excellent diagnostic performance of 2HG-MRS in the prediction of IDH mutant glioma, with pooled sensitivity and specificity of 95% and 91%, respectively [49]. The gene discussed is IDH1; the disease is central nervous system cancer.